Sherbrooke Park Advisers »

Prelude Therapeutics shares owned by Sherbrooke Park Advisers

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Sherbrooke Park Advisers from 13F filings

Historical chart of Sherbrooke Park Advisers investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Sherbrooke Park Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Sherbrooke Park Advisers

Quarter filed Position value Share count Share price at filing
2024-09-30 $42k 20k 2.07

More positions owned by Sherbrooke Park Advisers

Gap (GAP)
Smartsheet Com Cl A (SMAR)
Lennar Corp Cl A (LEN)
Pure Storage Cl A (PSTG)
Micron Technology (MU)
Campbell Soup Company (CPB)
Ida (IDA)
AeroVironment (AVAV)
Pagerduty (PD)
Devon Energy Corporation (DVN)
Korn Ferry Com New (KFY)
Cardinal Health (CAH)
ConAgra Foods (CAG)
Amazon (AMZN)
Cirrus Logic (CRUS)

View all positions for Sherbrooke Park Advisers

Top funds holding Prelude Therapeutics

OrbiMed Advisors
Baker Bros. Advisors
Boxer Capital Management
BlackRock
T. Rowe Price Associates
Vanguard Group
Jacobs Levy Equity Management
Renaissance Technologies
Massachusetts Financial Services
Acadian Asset Management
Millennium Management
Geode Capital Management
Marshall Wace
Morgan Stanley
Two Sigma Advisers

View all funds holding Prelude Therapeutics